The immunoprotective effect of sertoli cells coencapsulated with islet xenografts is not dependent upon Fas ligand expression

Cell Transplantation

Volumn 11, Issue 8, 2002, Pages 799-801

  Yang, Hua ^a   Al Jazaeri, Ayman ^a   Wright Jr , James R ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Alginate encapsulation; Fas ligand; Islet xenotransplantation; Sertoli cells

Indexed keywords

ALGINIC ACID; CALCIUM; FAS ANTIGEN; FAS LIGAND; GLUCOSE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL ENCAPSULATION; DIABETES MELLITUS; ENCAPSULATION; GRAFT SURVIVAL; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SERTOLI CELL; STREPTOZOCIN DIABETES; TESTIS CELL; TREATMENT OUTCOME; XENOTRANSPLANTATION;

ANIMALIA; MAMMALIA; TILAPIA;

EID: 0036987489     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000002783985288     Document Type: Article

References (10)

1. Korbutt, G. S.; Ao, Z.; Flashner, M.; Elliott, J. F.; Rajotte, R. V. Coencapsulation of allogeneic islets with allogeneic Sertoli cells prolongs graft survival without systemic immunosuppression. Transplant. Proc. 30:419; 1998.
2. Korbutt, G. S.; Elliott, J. F.; Rajotte, R. V. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 46:317-322; 1997.
3. Lau, H. T.; Yu, M.; Fontana, A.; Stoeckert, C. J., Jr. Prevention of islet allograft rejection with engineered myoblasts expressing Fas-L in mice. Science 273:109-112; 1996.
4. Luca, G.; Calvitti, M.; Neri, L. M.; Becchetti, E.; Capitani, S.; Basta, G.; Angeletti, G.; Fanelli, C.; Brunetti, P.; Calafiore, R. Sertoli cell-induced reversal of adult rat pancreatic islet beta-cells into fetal-like status: Potential implications for islet transplantation in type I diabetes mellitus. J. Invest. Med. 48:441-448; 2000.
5. Selawry, H. P.; Cameron, D. F. Sertoli cell enriched fractions in successful islet cell transplantation. Cell Transplant. 2:123-129; 1993.
6. Suarez-Pinzon, W.; Korbutt, G. S.; Power, R.; Hooton, J.; Rajotte, R. V.; Rabinovitch, A. Testicular Sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-betal-dependent mechanism. Diabetes 49:1810-1818; 2000.
7. Takeda, Y.; Gotoh, M.; Dono, K.; Nishihara, M.; Grochowiecki, T.; Kimura, F.; Yoshida, T.; Ohta, Y.; Ota, H.; Ohzato, H.; Umeshita, K.; Takeda, T.; Matsuura, N.; Sakon, M.; Kayagaki, N.; Yagita, H.; Okumura, K.; Miyasaka, M.; Monden, M. Protection of islet allografts transplanted together with allogeneic testicular cell allografts. Diabetologia 41:315-321; 1998.
8. Wright, J. R., Jr.; Pohajdak, B. Cell therapy for diabetes using piscine islet tissue. Cell Transplant. 10:125-1143; 2001.
9. Yang, H.; O'Hali, W.; Kearns, H.; Wright, J. R., Jr. Long-term function of fish islet xenografts in mice by alginate encapsulation. Transplantation 64:28-32; 1997.
10. Yang, H.; Wright, J. R., Jr. Co-encapsulation of Sertoli enriched testicular cell fractions further prolongs fish-to-mouse islet xenograft survival. Transplantation 67:815-820; 1999.